Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Association of Serpind1 Expression With Grade, Stage and Presence of Metastasis in Breast Cancer



Namini NM1 ; Abdollahi A2 ; Movahedi M1 ; Razavi AE3 ; Saghiri R4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Biochemistry, Faculty of Biological Sciences, North Tehran Branch, Islamic Azad University, Tehran, 19585/466, Iran
  2. 2. Department of Pathology, Imam Hospital Complex, Tehran University of Medical Sciences (TUMS), Tehran, 14197-33141, Iran
  3. 3. Iran National Tumor Bank, Cancer Biology Research Center, Cancer Institute of Iran, Tehran University of Medical Sciences, Tehran, 1419733141, Iran
  4. 4. Department of Biochemistry, Pasteur Institute of Iran, Tehran, 1316943551, Iran

Source: Indian Journal of Biochemistry and Biophysics Published:2021

Abstract

The role of SERPIND1 gene in the development of breast cancer is completely unknown. The aim of the present study was to assess the expression of SERPIND1 in patients suffering from breast malignancies. Tumoural specimens and non-tumoural adjacent tissues were collected from 31 patients who were pathologically confirmed for breast cancer. Furthermore, 43 fasting venous blood samples were collected from the breast cancer patients as well as from the healthy volunteers as control group. The SERPIND1 mRNA expression levels were assessed using the q-RT PCR while the plasma levels of SERPIND1 protein were detected using ELISA. The SERPIND1 relative expression levels were compared with the clinicopathological factors. The expression of the SERPIND1 was significantly higher at both mRNA and protein levels in breast cancer patients compared to the control groups. Moreover, the relative expression of the SERPIND1 showed a significant positive correlation with cancer grade, stage and presence of metastasis (P< 0.05). The findings suggest that the SERPIND1 may be a metastasis-enhancer factor in breast cancer and a strong predictive marker for distinguishing patients with poor prognosis. © 2021, National Institute of Science Communication and Information Resources. All rights reserved.